A private held company created with the objective of filling the very specific and special medical needs of a small population of adults and children seeking life-preserving therapeutics for rare diseases.
Following the leadership of our partners around the world and under the management of a highly experienced team, iMed Group pursues the objective of becoming the leader biopharmaceutical research company in Latin America .
We specialize in the development, marketing and distribution of products used to treat rare diseases where current therapies in Latin America are unavailable, incomplete or inadequate.The company is currently seeking strategic alliances and dedicated to acquiring, developing, registering and marketing high medical value specialty medicines.
nnovative Medicine